The current GMDA market cap is 43.32M. The company's latest EPS is ILS -0.5984 and P/E is -0.55.
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -18.05M | -17.06M | -20.56M | -19.58M | -18.8M |
Net Income | -18.55M | -17.8M | -22.8M | -20.96M | -31.68M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -33.64M | -48.25M | -62.3M | -87.17M | -74.99M |
Net Income | -52.93M | -34.35M | -72.7M | -89.79M | -79.38M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | |
Total Assets | 108.02M | 114.31M | 124.77M | 105.13M | 112.51M |
Total Liabilities | 100.17M | 100.75M | 132.8M | 120.5M | 138.22M |
Total Equity | 7.85M | 13.56M | -8.02M | -15.37M | -25.71M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | |
Total Assets | 65.16M | 68.78M | 155.48M | 148.79M | 124.77M |
Total Liabilities | 40.48M | 33.79M | 56.75M | 104.85M | 132.8M |
Total Equity | 24.69M | 34.98M | 98.74M | 43.94M | -8.02M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | |
Operating | -39.59M | -54.25M | -70.42M | -22.28M | -44.29M |
Investing | 21.43M | 31.05M | 34.04M | -827k | -821k |
Financing | 160k | 22.37M | 45.14M | 5.22M | 34.66M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | |
Operating | -26.43M | -37.93M | -48.63M | -81.76M | -70.42M |
Investing | -2.75M | 3.67M | 1.59M | -60.92M | 34.04M |
Financing | 48.09M | 35.73M | 132.38M | 71.4M | 45.14M |
Market Cap | 43.32M |
Price to Earnings Ratio | -0.55 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.68 |
Price to Book Ratio | -5.46 |
Dividend Yield | - |
Shares Outstanding | 132.64M |
Average Volume (1 week) | 3.32M |
Average Volume (1 Month) | 3.73M |
52 Week Change | -78.51% |
52 Week High | 2.51 |
52 Week Low | 0.2184 |
Spread (Intraday) | 0 (0.49%) |
Company Name | Gamida Cell Ltd |
Address |
5 nahum heftsadie street jerusalem, jerusalem 91340 |
Website | https://www.gamida-cell.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.